For middle-income countries looking to diversify their economies and graduate to high-income status, IPRs are more important today than at any other point in history. Using compulsory licenses to achieve public health objectives is short-termist, anachronistic and counterproductive in the long run.
Director of Research at Aequitas Health Consulting
Amir Ullah Khan is Visiting Professor of the Indian School of Business, and director of research at Aequitas Health Consulting, New Delhi.
Amir started his career in the Indian Civil Service and has worked for the Government of India, the UNDP, The Indian Development Foundation and headed editorial operations at Encyclopedia Britannica India. He has also worked for the Bill and Melinda Gates Foundation as a policy advisor.
India’s home grown medicine innovators are on the march but face legal and policy challenges. An innovative diabetes treatment from an Indian biotech company is set to transform the lives of 387 million people living with the condition globally.